We established a simple IL-2-dependent colony-forming assay for T cells infected with human T-lymphotropic virus type-I (HTLV-I). IL-
Introduction
Adult T cell leukemia/lymphoma (ATL) is a malignant tumor of mature helper T cells infected with human T lymphotropic virus type-I (HTLV-I). [1] [2] [3] [4] The virus is also etiologically related to HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). 5 The HTLV-I genome consists of three structural genes, gag, pol and env, and a regulatory region, pX. 6 Tax, a protein encoded in the pX region, 4 transactivates the transcription of not only the proviral genes 7, 8 but also many cellular genes such as those of interleukin(IL)-2/IL-2 receptor (IL-2R), 9 ,10 IL-3, IL-4, IL-6, granulocyte-macrophage colony-stimulating factor, c-fos and c-jun. It has been postulated that in the carrier state, transactivation of several cellular genes enhances the multiclonal growth of normal lymphocytes infected with HTLV-I, and that certain activity of cellular genes ultimately leads to the establishment of malignant phenotypes in a single group of lymphocytes, leading to a clonal disease state. Most curiously, cell growth of fully advanced ATL tumor cells is not dependent on proviral genCorrespondence: T Hata, Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University School of Medicine, 1-12-4 Sakamoto, Nagasaki 852-8102, Japan; Fax: 81 95 849 7113 Received 15 June 1998; accepted 22 October 1998 ome activity. The underlying mechanism of this freedom from viral gene remains to be elucidated to fully understand ATL leukemogenesis.
ATL, a disease with variable clinical features and prognosis, is classified into smoldering, chronic, lymphoma and acute subtypes. 11 In addition, a molecularly detectable pre-ATL state exists in healthy HTLV-I carriers. 12 The probability of progression to fully advanced acute ATL is higher in patients with prodromal pre-ATL, smoldering, and chronic phases of ATL. 13 T cells of normal peripheral blood do not grow spontaneously in vitro or become cell lines. However, normal T cells can be induced to grow in liquid as well as in semisolid culture medium after transfection with HTLV-I.
14,15 T cells from the peripheral blood of HTLV-I carriers or HAM/TSP patients spontaneously form colonies in methylcellulose and actively produce viral particles. 16 In contrast, primary tumor cells from the peripheral blood of ATL patients do not usually show a similar spontaneous growth, and do not respond to exogenously added IL-2. 17 However, there is no established theory to explain the relationship between these clinical subtypes and IL-2-dependency or IL-2-independency.
The aim of the present study was to establish a colony forming assay for T lymphocytes infected with HTLV-I and to investigate IL-2-dependency of T cells in HTLV-I carriers and various subtypes of ATL.
Materials and methods

HTLV-I carriers and ATL patients
The diagnosis of ATL was based on the presence of anti-HTLV-I antibodies, clinical features, hematological and cytological findings, surface phenotypes, and the integration of HTLV-I proviral DNA by Southern blot analysis. ATL was clinically classified according to the Japanese Lymphoma Study Group (LSG). 11 In addition to these criteria, we added another subtype; crisis ATL, which was defined as cases of either smoldering or chronic subtype which eventually transformed into acute ATL. In this study, patients with lymphoma subtype were excluded due to the difficulty in obtaining primary tumor cells from the peripheral blood.
Heparinized peripheral blood was obtained after informed consent and prior to any medication from 31 healthy HTLV-I carriers, 45 patients with ATL (including 12 smoldering subtype, 11 chronic subtype, 12 crisis subtype and 10 acute subtype) and three HTLV-I-seronegative healthy controls.
Cell separation
Peripheral blood mononuclear cells (PBMNC) were separated from heparinized peripheral blood samples by Ficoll-Conray density gradient centrifugation. Cells were washed twice with Iscove's medium (IMDM), and incubated in the presence of carbonyl iron and 10% fetal calf serum (FCS) in a plastic culture flask at 37°C in a humidified atmosphere of 5% CO 2 in air for 30 min. Phagocytes with ingested carbonyl iron were separated from PBMNC using a strong magnet, yielding a lymphocyte-rich fraction.
Formation of primary T cell colony
PBMNC fractions containing 2 × 10 5 lymphocytes/ml were cultured in 0.93% methylcellulose containing IMDM and 20% FCS with or without 200 ng/ml recombinant human IL-2 (rIL-2) (kindly provided by Takeda Chemical Industries, Osaka, Japan) in triplicate 35 mm plastic Petri dishes at 37°C in a humidified atmosphere of 5% CO 2 in air. In a few experiments, 1-30 g/ml of anti-IL-2R␣ monoclonal antibody (mAb) (B-B 10; Diaclone Research, France) was added. Aggregates of more than 50 cells were counted as primary colonies using an inverted microscope (Olympus, Tokyo, Japan).
Establishment of cell lines from primary colonies
Following the formation of colonies from each case, approximately 20 colonies were picked up after 21 days in culture using a manipulating micropipette. The colonies were transferred individually into IMDM containing 20% FCS and 20 ng/ml rIL-2 and cultured at 37°C in a humidified atmosphere of 5% CO 2 in air. The culture medium was changed once a week and the clones showing a continuous growth after 6 months were defined as cell lines.
Surface phenotyping and detection of viral proteins
Surface phenotypes of fresh ATL cells and cells of established cell lines were examined by flow cytometry (Cytoron; Ortho Diagnostic Systems, Tokyo, Japan) using a panel of mAbs including CD4 and CD8 as previously described. 18 Colonycomposing cells and clones in early expansion phase in liquid culture were examined immunocytochemically for CD4 and CD8 by Leu3a and Leu2a, respectively. For immunocytochemistry, cytospin preparations were stained using streptoavidine-biotin-alkaline phosphatase labeling method as described previously. 19 Furthermore, to immunocytochemically detect HTLV-I proteins of colony-composing cells and cell lines, we used anti-gag p19 mAb (sera-lab) and anti-p40tax mAb ).
Southern blot hybridization
To investigate the clonal relationship between fresh ATL cells and established cell lines, Southern blot analysis of the integration bands of HTLV-I proviral genome and TCR␤ gene were performed as described previously. 13, 21 Briefly, high molecular weight cellular DNA was extracted from PBMNCs and cell lines, 10 g of DNA was digested with restriction enzymes such as EcoRI, PstI or HindIII, electrophoresed in 0.7% agarose gel, then transferred on to a nitrocellulose filter. The filters were hybridized with randomly-primed 32 P-labeled DNA probes specific for HTLV-I gene and TCR␤ gene. When DNA was digested with EcoRI, we used the 2.3 kb BamHISmaI fragment of HTLV-I pX region (kindly provided by Dr Ryozo Moriuchi, Nagasaki University, Nagasaki, Japan). In the case of PstI-digested DNA, we used the 6.8 kb of 5ЈLTR-pX region and 0.9 kb of pX-3ЈLTR region of HTLV-I. The TCR␤ gene probe used was 0.7 kb EcoRI-BamHI fragment (kindly provided by Dr Tatsuroh Joh, Aichi Cancer Center Research Institute, Nagoya, Japan) or 1.1 kb EcoRI-HindIII fragment containing human TCR C␤2 gene. Finally, the filters were washed and autoradiographed.
Statistical analysis
Statistical analysis was performed using SAS program. Differences between groups were examined for statistical significance using the Fisher's exact test or Mann-Whitney U test. Correlation between colony counts and hematological findings were evaluated by Spearman's rank correlation. A P value Ͻ0.05 denoted the presence of a statistically significant difference.
Results
Clinical characteristics of ATL patients and HTLV-I carriers
As shown in Table 1 , the mean WBC count and absolute number of lymphocytes were significantly higher in patients with chronic, crisis and acute subtypes than in HTLV-I carriers. The percentage of abnormal lymphocytes in patients with ATL was significantly higher than in HTLV-I carriers. Serum LDH and calcium levels were similar between carriers, smoldering and chronic categories, but tended to be higher in patients with crisis and acute subtypes. There were no differences in the mean values of all parameters between patients with crisis ATL and acute ATL.
IL-2-dependent colony formation
Colonies began to form on day 5 to 7 after seeding. The size and number of colonies gradually increased, reaching a maximum number (200-1000 cells) on day 20 in most cases. Two distinct forms of colonies were identified: a single solitary colony and multicentric burst colony.
We determined the cell proliferation dose-response curve for IL-2 as shown in Figure 1 , and the optimal dose of IL-2 resulting in a maximum number of colonies was 200 ng/ml. The addition of anti-IL-2R␣ mAb inhibited the proliferative response to IL-2 in a dose-response manner as shown in Figure 2 . In the absence of IL-2, no spontaneous colony formation was observed as shown in Table 2 . No colonies were formed even following IL-2 stimulation in three normal controls and all cases of the acute subtype. In contrast, colony formation was observed in all cases of carriers, smoldering and chronic ATL, and in 10 (83.3%) of 12 crisis cases, although the number of colonies varied widely among different groups and within the group. The number of colonies significantly correlated with the volume of prodromal ATL clones represented by WBC count, absolute number of lymphocytes, 
9.1 ± 0.5 9.2 ± 0.7 9.1 ± 0.5 10.4 ± 1.7 11.9 ± 3.5
Data are mean ± s.d. percent CD4, and in particular, the absolute number of abnormal lymphocytes (Table 3 ).
Establishment of cell lines
During clonal expansion in IL-2-containing liquid cultures, most clones ceased to grow and gradually died within 3 months. However, one or more clones in each case eventually became cell lines. The rate of establishment of cell line was significantly lower in the carrier category than in other three subtypes (P Ͻ 0.01, Table 4 ). All cell lines showed persistent growth during a period of 1 year. A reduction in IL-2 concentration in liquid culture did not affect the growth or viability of cell lines. The minimum amount of IL-2 required to sustain growth of cell line was 10 ng/ml. However, the cells showed a rapid fall in the growth rate following depletion of IL-2, indicating IL-2-dependency.
Morphology, surface phenotypes and expression of viral proteins
Established cell lines contained cells with indented or lobulated nuclei, similar to peripheral blood cells. The surface phenotypes of cells from primary colonies, clones in early expansion phase in liquid culture, and cell lines were mostly CD4 + CD8
− . The proportions of CD4
− CD8 − and CD4 + CD8 + were 90.8%, 2.1%, 3.5% and 3.5%, respectively. Immunocytochemical examination showed a strong staining pattern by anti-p19 mAb in all these cells and a weak to moderately strong staining pattern by antip40tax mAb in approximately 10-20% of cells.
Clonal analysis of cell lines by HTLV-I integration and TCR ␤ rearrangement
Chronic ATL case HO showed that cell line HO1 had two HTLV-I provirus integration bands, one with a site identical to that of fresh PBMNC and another additional faint but different band ( Figure 3A-a) . However, the TCR␤ rearrangement band was identical to that of fresh PBMNC ( Figure 3A-b) . This might be explained by superinfection with HTLV-I during expansion of the culture to establish cell lines. Therefore, HO1 seemed to be clonally identical to PBMNC in HO. In crisis ATL, cell line ST1 of case ST ( Figure 3B-a and b) and three cell lines (OA51, OA103 and OA54) of case OA were also clonally identical to fresh ATL cells. These three cases showed that cell lines were clonally identical with those of fresh PBMNC in each case and were designated as group A. In all 10 smoldering cases, five of seven chronic cases, and five of seven crisis cases, cell lines were clonally different from those of fresh PBMNC and were also different among established cell lines in each case. These cases were designated as group B ( Figure 3C ). Since we did not detect the integration band of PBMNC in any carrier cases, we could not compare the clonality of cell lines with PBMNC. In five of seven carrier cases, HTLV-I provirus integration bands and TCR rearrangement bands were different among several established cell lines in each case. Accordingly, these cases were also designated as group B.
In a carrier case FR, the site of integration band of HTLV-I provirus with EcoRI-digested DNA seemed to be identical among four cell lines. However, the site of the integration Table 4 Rate of cell line establishment and clonality analysis according to prodromal subtypes band of HTLV-I provirus with PstI-digested DNA was identical between FR13 and FR14 but was different from that in FR8 and FR9 (Figure 3D-a) . This clonal relationship was supported by the TCR␤ rearrangement ( Figure 3D-b) . In chronic case KR, HTLV-I integration bands of cell lines KR7, KR8, and KR9 were all identical and also identical to those of fresh PBMNC ( Figure 3E-a) . The TCR␤ rearrangement bands were identical among KR7, KR8 and KR9, but were apparently different from those of fresh PBMNC ( Figure 3E-b) . The cell lines of these cases were clonally different from those of PBMNC but were identical among established cell lines in each case. These cases were designated as group C.
Discussion
The present study showed that our method is highly efficient in preparing IL-2-dependent cell lines from individual colonies through expansion in liquid culture. The clonogenic cells are mostly CD4 + , CD8 − and p19 + HTLV-I-infected T cells using IL-2/IL-2R signaling for cell growth. Although proviral gene expression is usually not detected in fresh ATL cells by immunofluorescence or RNA blot analysis, it has been observed using reverse transcriptase-polymerase chain reaction (RT-PCR). [22] [23] [24] The colony number of 1 to 3 per 10 5 cells observed in carriers in our assay is equal to the lowest proviral gene expression in carriers previously reported using RT-PCR. It is possible that T cells expressing proviral genes are the colony-forming cells in our assay system. If confirmed, our method would be considered a very sensitive assay to detect carrier lymphocytes in HTLV-I-seropositive individuals. Moreover, this assay provides a small amount of carrier lymphocytes as a clone. This is important since no other method is currently available to obtain such a clonal population. In previous reports, IL-2-dependent T cell lines established in bulk liquid culture are usually clonally different from true ATL cells. [25] [26] [27] These cell lines were considered to be derived from either carrier lymphocytes or normal lymphocytes infected de novo with the virus in vitro. In the present study using clonal cultures, the origin of cell lines clonally distinct from dominant ATL cells, is not clear, but could be explained by one of three possibilities. First, these cells are derived from contaminated normal T cells, which were infected de novo with HTLV-I in vitro. Second, carrier lymphocytes which were virally transformed but biologically normal, are the clonogenic cells for the cell lines. Third, the clonogenic cells may also be virally transformed and acquired certain genetic abnormalities, resulting in a growth advantage over normal carrier lymphocytes. In a series of experiments from our laboratory, Fujimoto et al 28 showed that most colonies formed by co-cultivation of equal numbers of PBMNC from a female patient with chronic ATL and PBMNC from a normal male subject did not contain the y-body, indicating that the origin of these colonies was exclusively T cells of the female ATL patient. This observation suggested that de novo infection of contaminating normal lymphocytes with HTLV-I is unlikely. Furthermore, since the rate of establishment of cell lines in HTLV-I carriers was significantly lower than that in patients of prodromal phase ATL, we speculated that there were some differences in the growth capacity between lymphocytes of carriers and those of other prodromal phases of ATL.
Although fresh ATL cells express IL-2R ␣ constitutively, only 20% of ATL cases show a proliferative response to IL-2 when they are cultured in liquid media. 17, 22 On the other hand, spontaneous proliferation of PBMNC is often observed in HAM/TSP, 16, 29, 30 and to a lesser degree in HTLV-I carriers and was almost negative in ATL patients. 22 Moreover, such a spontaneous proliferation could be inhibited by anti IL-2R Ab. 22, 29 The overall data suggest that IL-2/IL-2R signaling is involved in HTLV-I carriers but not in fully advanced ATL 22 although Arima et al 31 indicated that IL-2 was involved in autocrine growth of ATL cells even in acute ATL. Migone et al 32 speculated that a constitutively activated Jak-STAT pathway might be involved in the transition from IL-2-dependent to IL-2-independent growth. The present study is different from previous studies in using fractionated PBMNC, and to our knowledge, there is no report that has defined the relationship between clinical subgroups of ATL and IL-2-dependency. We speculate that the IL-2/IL-2R signaling pathway is a minimal prerequisite for HTLV-I-infected T cells to form colonies and further acquisition of other growth mechanisms enhance the growth potential of clonogenic cells to become cell lines. Cell lines of group A suggest that some clones of prodromal ATL apparently maintain their response to IL-2 for cell growth.
Several recent studies using inverse PCR or ligation PCR
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showed multiclonal expansion of HTLV-I-bearing cells in carriers, 33, 34 and the presence of several minor clones in overt ATL. 35 In our previous study, Tsukasaki et al 21 showed occasional clonal changes during clinical progression from the prodromal phases to acute ATL. The results of our assay suggest the presence of four different types of HTLV-I-infected T-cells: (1) normal carrier T cells capable of forming primary colonies but unable to become cell lines in response to IL-2; (2) pre-malignant T cells capable of forming primary colonies as well as cell lines; (3) malignant ATL cells which exist as a dominant clone in vivo and are capable of forming primary colonies as well as cell lines; (4) fully malignant T cells totally unresponsive to IL-2 or acquired some novel growth signaling pathway that inhibits the former signaling. In the prodromal phases of ATL, these four components seem to be present as a mixture of multiclones at various ratios. It is interesting to note that although the clinical parameters of crisis and acute subtypes are similar, the efficiency of primary colony formation was extremely different between them. This observation suggests that the simple clinical subclassification of LSG does not necessarily reflect the presence of similar pathological features in these categories.
In conclusion, the assay described in the present study identified multiclonal expansion of unique HTLV-I-infected T cells with a high growth potential in response to IL-2 in the prodromal phase of ATL and a lack of such dependency in fully advanced ATL. Extension of our clonal studies to elucidate pathological changes in signal transduction and proviral gene expression is important in order to fully understand the leukemogenesis of HTLV-I-infected T cells. Our assay must be further tested to establish whether it can predict carriers who can potentially develop ATL.
